Nuzenio

Peak Trial Enrollment

Peak Trial Enrollment news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Kodiak Sciences (KOD) Is Up 9.1% After Advancing KSI-101 Phase 3 PEAK Trial Enrollment – Has The Bull Case Changed? - simplywall.stsimplywall.st · Sun, 09 Aug 2026 08:50:32 GMT Kodiak's Trial Tests KSI-101 for Macular Edema Secondary to Inflammation - Stock TitanStock Titan · Thu, 06 Aug 2026 11:00:00 GMT Summit Therapeutics Launches HARMONi-GU1 Trial for Ivonescimab in Bladder Cancer - The Clinical Trial VanguardThe Clinical Trial Vanguard · Thu, 06 Aug 2026 06:43:58 GMT Summit Therapeutics (NASDAQ: SMMT) launches Phase II/III HARMONi-GU1 bladder cancer study - Stock TitanStock Titan · Wed, 05 Aug 2026 11:32:48 GMT Summit’s Global Bladder Cancer Trial Aims to Enroll About 800 Patients - Stock TitanStock Titan · Wed, 05 Aug 2026 11:00:00 GMT The Rare Trials Summit Wants To Produce More Than Conversation - Clinical LeaderClinical Leader · Mon, 03 Aug 2026 07:56:59 GMT

Timeline

Sun, 09 Aug 2026 08:50:32 GMTKodiak Sciences (KOD) Is Up 9.1% After Advancing KSI-101 Phase 3 PEAK Trial Enrollment – Has The Bull Case Changed? - simplywall.st

Thu, 06 Aug 2026 11:00:00 GMTKodiak's Trial Tests KSI-101 for Macular Edema Secondary to Inflammation - Stock Titan

Thu, 06 Aug 2026 06:43:58 GMTSummit Therapeutics Launches HARMONi-GU1 Trial for Ivonescimab in Bladder Cancer - The Clinical Trial Vanguard

Wed, 05 Aug 2026 11:32:48 GMTSummit Therapeutics (NASDAQ: SMMT) launches Phase II/III HARMONi-GU1 bladder cancer study - Stock Titan

Wed, 05 Aug 2026 11:00:00 GMTSummit’s Global Bladder Cancer Trial Aims to Enroll About 800 Patients - Stock Titan

Mon, 03 Aug 2026 07:56:59 GMTThe Rare Trials Summit Wants To Produce More Than Conversation - Clinical Leader

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Kodiak Sciences2 live mentions KOD2 live mentions Is Up2 live mentions After Advancing KSI2 live mentions Phase2 live mentions Has The Bull2 live mentions Case Changed2 live mentions Trial Tests KSI2 live mentions Macular Edema Secondary2 live mentions Stock Titan2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Peak Trial Enrollment.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.